Quantigen

Founded in 2008, Quantigen Biosciences grew into a high-throughput contract research and assay development organization operating a 40,000-square-foot facility in Fishers, Indiana. For more than a decade, Quantigen scientists have specialized in sample-to-answer method development and validation across a broad array of applications, leveraging expertise in molecular biology, biotechnology, and regulatory oversight to design customized, cost-effective workflows for clients in three core areas: Basic and Preclinical Research, Clinical and Translational Research, and Clinical Diagnostics. In July 2023, Quantigen joined the Versiti Clinical Trial Services family, expanding its reach and integrating its robust capabilities within a broader clinical trials ecosystem.